Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hannes, Fohler"'
Autor:
Michael, Gnant, Amylou C, Dueck, Sophie, Frantal, Miguel, Martin, Hal J, Burstein, Richard, Greil, Peter, Fox, Antonio C, Wolff, Arlene, Chan, Eric P, Winer, Georg, Pfeiler, Kathy D, Miller, Marco, Colleoni, Jennifer M, Suga, Gabor, Rubovsky, Judith M, Bliss, Ingrid A, Mayer, Christian F, Singer, Zbigniew, Nowecki, Olwen, Hahn, Jacqui, Thomson, Norman, Wolmark, Kepa, Amillano, Hope S, Rugo, Guenther G, Steger, Blanca, Hernando Fernández de Aránguiz, Tufia C, Haddad, Antonia, Perelló, Meritxell, Bellet, Hannes, Fohler, Otto, Metzger Filho, Anita, Jallitsch-Halper, Kadine, Solomon, Céline, Schurmans, Kathy P, Theall, Dongrui R, Lu, Kathleen, Tenner, Christian, Fesl, Angela, DeMichele, Erica L, Mayer
Publikováno v:
Journal of Clinical Oncology. 40:282-293
PURPOSE Palbociclib is a cyclin-dependent kinase 4 and 6 inhibitor approved for advanced breast cancer. In the adjuvant setting, the potential value of adding palbociclib to endocrine therapy for hormone receptor–positive breast cancer has not been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbc01917bf87e41cb5637a9f1fd33c18
https://doi.org/10.1200/jco.21.02554
https://doi.org/10.1200/jco.21.02554
Autor:
Michael Gnant, Sophie Frantal, Georg Pfeiler, Guenther G. Steger, Daniel Egle, Richard Greil, Florian Fitzal, Viktor Wette, Marija Balic, Ferdinand Haslbauer, Elisabeth Melbinger-Zeinitzer, Vesna Bjelic-Radisic, Silvia Artner-Matuschek, Franz Kainberger, Magdalena Ritter, Gabriel Rinnerthaler, Paul Sevelda, Jonas Bergh, Stephanie Kacerovsky-Strobl, Christoph Suppan, Christine Brunner, Christine Deutschmann, Simon P. Gampenrieder, Hannes Fohler, Raimund Jakesz, Christian Fesl, Christian Singer
Publikováno v:
NEJM Evidence. 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf0e4ae6c9ca6f920ac1c0f0b4b9f2cb
https://doi.org/10.1056/evidoa2200162
https://doi.org/10.1056/evidoa2200162
Autor:
Ana-Alicia Beltran-Bless, Mark J. Clemons, Christian Fesl, Richard Greil, Gregory R. Pond, Marija Balic, Lisa Vandermeer, Vesna Bjelic-Radisic, Christian F. Singer, Guenther G. Steger, Ruth Helfgott, Daniel Egle, Lidija Sölkner, Simon P. Gampenrieder, Stephanie Kacerovsky-Strobl, Christoph Suppan, Magdalena Ritter, Gabriel Rinnerthaler, Georg Pfeiler, Hannes Fohler, Dominik Hlauschek, John Hilton, Michael Gnant
Publikováno v:
European journal of cancer (Oxford, England : 1990). 180
The widespread adoption of adjuvant bisphosphonate therapy for postmenopausal early breast cancer (EBC) patients was based on results of the Early Breast Cancer Trialist Group (EBCTCG) meta-analysis. Despite multiple regimens evaluated, there was no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91894cf1d4f4cc54b48d7c4f424218a4
https://pubmed.ncbi.nlm.nih.gov/36592505
https://pubmed.ncbi.nlm.nih.gov/36592505
Autor:
Ana-Alicia Beltran-Bless, Mark Clemons, Christian Fesl, Dominik Hlauschek, Lidija Soelkner, Gregory R. Pond, Lisa Vandermeer, Richard Greil, Marija Balic, Vesna Bjelic-Radisic, Christian F. Singer, Guenther Steger, Ruth Helfgott, Daniel Egle, Simon P. Gampenrieder, Stephanie Kacerovsky-Strobl, Christoph Suppan, Magdalena Ritter, Gabriel Rinnerthaler, Georg Pfeiler, Hannes Fohler, John Hilton, Michael Gnant
Publikováno v:
Cancer Research. 83:P2-02
Background: The results of the Early Breast Cancer Trialist Group (EBCTCG) meta-analysis (Lancet 2015) led to the widespread adoption of bisphosphonates as adjuvant therapy for postmenopausal early-stage breast cancer (EBC). Despite evaluating multip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef237d8d475c0660075fdcdbf77297bf
https://doi.org/10.1158/1538-7445.sabcs22-p2-02-04
https://doi.org/10.1158/1538-7445.sabcs22-p2-02-04
Autor:
Julie Lemieux, Michael Gnant, Amylou C. Dueck, Georg Pfeiler, Meritxell Bellet-Ezquerra, Antonio C. Wolff, Magdalena Schwarz, Marcus Vetter, Angela DeMichele, Kathy D. Miller, Kathy Puyana Theall, Miguel Gil-Gil, Hannes Fohler, Patrick G. Morris, Maria Koehler, Stacy L. Moulder, Matthew Bidwell Goetz, Manuel Ruiz-Borrego, Arlene Chan, Aleix Prat, G. Rubovszky, Silvia Antolin Novoa, Otto Metzger Filho, Miguel Martín, Debora Fumagalli, Erica L. Mayer, D. Lu, Fernando Henao, Christian Fesl, Eric P. Winer, Florian Fitzal, Alistair Ring, Tiffany A. Traina, Carter Dufrane, Harold J. Burstein, Sibylle Loibl, Nicholas Zdenkowski, Daniel Egle, Hope S. Rugo, Cynthia Huang Bartlett, Daniel G. Anderson, Eleftherios P. Mamounas, Alan P. Lyss, Zbigniew Nowecki
Publikováno v:
The Lancet. Oncology
Summary Background Palbociclib added to endocrine therapy improves progression-free survival in hormone-receptor-positive, HER2-negative, metastatic breast cancer. The PALLAS trial aimed to investigate whether the addition of 2 years of palbociclib t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6787d365738e1b450b902b6d51989545
https://doi.org/10.1016/s1470-2045(20)30642-2
https://doi.org/10.1016/s1470-2045(20)30642-2
Autor:
M. Gnant, Hannes Fohler, AM DeMichele, Kathy D. Miller, M. Martin, EP Winer, Daniel G. Anderson, Zbigniew Nowecki, Erica L. Mayer, K. Puyana Theall, S. Loibl, Christian Fesl, Harold J. Burstein, Nicholas Zdenkowski, Otto Metzger, Georg Pfeiler, Debora Fumagalli, Aleix Prat, G. Rubovszky, Amylou C. Dueck
Publikováno v:
Annals of Oncology. 31:S1145
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e4cd2673f908b95378084fbc6a97b70
https://doi.org/10.1016/j.annonc.2020.08.2240
https://doi.org/10.1016/j.annonc.2020.08.2240
Autor:
Raimund Jakesz, Hannes Fohler, Peter Blaha, Richard Greil, Peter Dubsky, Katharina Hüttner, Florian Fitzal, Sebastian F. Schoppmann, Hellmut Samonigg, Michael Gnant, Christian Marth, Ernst Ruecklinger, Günther G. Steger
Publikováno v:
Clinical breast cancer. 9
Women undergoing treatment for breast cancer often experience a marked decrease in bone mineral density. This decrease is observed with chemotherapy as well as endocrine therapy and is more pronounced and rapid than normal postmenopausal bone loss. P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05b4037590ac5ea81978044d786e95c8
https://pubmed.ncbi.nlm.nih.gov/19561003
https://pubmed.ncbi.nlm.nih.gov/19561003